Sign in

CIK 0000949858

  • Non-accelerated filer
  • Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Tickers
ACHV QUIT
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
954343413
Phone
+1 425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC

Securities

  • ACHV Common stock Nasdaq
  • QUIT Common Shares Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$175,177
in 1 filing

Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Stewart Richard Alistair −$175K Director sold 9% of stake
Date Insider Transaction Shares Price Value Owned after
2022-05-31 Joseph Donald Director Grant or award · Stock Option (right to buy) +4,400 4,400
2021-05-11 Joseph Donald Director Grant or award · Stock Option (right to buy) +3,750 3,750
2020-05-12 Joseph Donald Director Grant or award · Stock Option (right to buy) +22,000 22,000
2019-05-14 Joseph Donald Director Grant or award · Stock Option (right to buy) +7,000 7,000
2018-09-20 Joseph Donald Director Grant or award · Stock Option (right to buy) +12,000 12,000
2017-08-01 Joseph Donald Director Grant or award · Stock Option (right to buy) +16,400 16,400
2017-08-01 Joseph Donald Director Grant or award · Stock Option (right to buy) +16,400 16,400

Page 1 of 1 · 7 trades